Benelux
Benelux: New investments slow down while large exits abound
New investments in the Benelux region have been subdued, but a number of large exits have bumped up Q1's figures
VC-backed biotechs sustain faint pulse of Benelux healthcare
Uncertain policies have caused a slow down for healthcare buyouts in Benelux
Bedell opens new office in Luxembourg
Expansion is supported by the appointment of two new directors, Anne-Catherine Grave and Catherine Koch
Competitive 2016 ahead for booming Benelux
A look back on PE activity in Benelux reveals a competitive year ahead for the region
Benelux Q3 dealflow remains subdued but value rockets
Dealflow remained subdued in Q3 but value soared thanks to handful of larger deals
Fee transparency debate takes hold in Netherlands
Increasing pressure coming from LPs around fees hits GPs in the Netherlands
Benelux Q1 activity delivers increase in 'pass-the-parcel' deals
SBOs are creeping up in the region, but corporate spinoffs are also on the rise
Towerbrook buys Ad Van Geloven in SBO
Lion had bought the business from Egeria in 2008
3i makes three hires across Europe and US
3i recruits Rinnert, Vos and Bernard to European and US offices
Benelux activity strengthens despite controversies
From LuxLeaks to a $250m funding round – Benelux experienced a varied year
Benelux healthcare funds and exits prosper while dealflow dips
VC healthcare investments in Benelux have dipped but fund closes and exits abound
Benelux sees summer uptick
Despite the summer break the Benelux region has seen strong dealflow